Filter
211
Text search:
pharmaceutical
regulatory
authority
Featured
Recommendations
16
New Publications
60
Language
Document type
No document type
109
Studies & Reports
42
Guidelines
31
Strategic & Response Plan
13
Manuals
8
Fact sheets
3
Resource Platforms
2
Training Material
1
Brochures
1
Situation Updates
1
Countries / Regions
Ethiopia
13
Ghana
9
Kenya
9
South Africa
9
India
8
Uganda
7
Zimbabwe
7
Tanzania
6
Malawi
6
Zambia
5
Rwanda
5
Liberia
3
Nigeria
3
Nepal
3
Syria
3
Bangladesh
3
Botswana
3
Western and Central Europe
3
Eastern Europe
3
Global
3
Sierra Leone
2
Senegal
2
Cameroon
2
South–East Asia Region
2
Philippines
1
Pakistan
1
Jordan
1
Chad
1
Cambodia
1
Papua New Guinea
1
Sudan
1
Benin
1
Namibia
1
Eswatini/ Swaziland
1
North Macedonia
1
Ukraine
1
Lesotho
1
East and Southern Africa
1
West and Central Africa
1
Middle East and North Africa
1
Asia
1
Albania
1
Timor Leste/ East Timor
1
Gabon
1
Denmark
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
109
Clinical Guidelines
9
Pharmacy & Technologies
9
Key Resources
8
Women & Child Health
5
Public Health
4
Capacity Building
1
Toolboxes
AMR
29
Pharmacy
28
COVID-19
15
TB
11
HIV
9
Mental Health
6
Rapid Response
4
NTDs
3
Conflict
2
Refugee
2
Specific Hazards
2
Global Health Education
2
Natural Hazards
1
Zika
1
Planetary Health
1
Health Financing Toolbox
1
NCDs
1
Malaria
1
2.0 Rapid Response
1
Interim Guidance October 2022. This addendum addresses some of the methodological aspects of VE evaluations that have been learned during the past year, as well as those that have become relevant in the current epidemiological setting of the COVID-19 pandemic. For some of the COVID-19 vaccine method
...
Report of a mission 20–24 April 2015
The WHO Model List of Essential Medicines and Model List of Essential Medicines for Children are updated and published every two years, intended as a guide for countries or regional authorities to adopt or adapt in accordance with local priorities and treatment guidelines for the development and upd
...
Despite high regional demand for vaccines valued at over US$ 1 billion annually, Africa’s vaccine industry provides only 0.1% of global supply. Vaccine inequity and hoarding at the start of the pandemic, which resulted in delays in obtaining COVID-19 doses, stimulated new resolve to address future
...
Submitted to the US Agency for International Development by the
Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program.
This manual provides a framework to identify problems and design interventions to improve access to and use of medicines for children. It is a resource for
...
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi
...
This document is a guide defining requirements for quality and safety for malaria rapid diagnostic testing services to safeguard the quality of the results, the safety of the operators and patients and that of the environment for use by national malaria control programmes, regulators, implementers a
...
The prevalence, availability, and use of antimalarial medicines (AMLs) were studied in six Cambodian provinces along the Thai-Cambodian border. The study was divided into two parts: the first looked at the quality of AMLs available in Pursat, Pailin, Battambang, Bantey Meanchey, Oddar Meanchey, and
...
Strategic Overview
USAID Senegal and Health in Africa (HIA) initiative of the World Bank Group engaged the Strengthening Health Outcomes through the Private Sector (SHOPS) project to conduct an assessment of the private health sector in Senegal. The assessment’s primary focus is family planning, and its secondary fo
...
